Search

Farley J. Abad

Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )

Most Active Art Unit
2181
Art Unit(s)
2181
Total Applications
1076
Issued Applications
864
Pending Applications
101
Abandoned Applications
140

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4676120 [patent_doc_number] => 20080213750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'HCV Variants and Related Methods' [patent_app_type] => utility [patent_app_number] => 11/960391 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31504 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213750.pdf [firstpage_image] =>[orig_patent_app_number] => 11960391 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/960391
Cell lines permissive for HCV replication Dec 18, 2007 Issued
Array ( [id] => 263611 [patent_doc_number] => 07569374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'HCV RNA-dependent RNA polymerase' [patent_app_type] => utility [patent_app_number] => 12/002392 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 4546 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569374.pdf [firstpage_image] =>[orig_patent_app_number] => 12002392 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/002392
HCV RNA-dependent RNA polymerase Dec 16, 2007 Issued
Array ( [id] => 6588160 [patent_doc_number] => 20100291542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'RAPID IMMUNOCHROMATOGRAPHIC DETECTION BY AMPLIFICATION OF THE COLLOIDAL GOLD SIGNAL' [patent_app_type] => utility [patent_app_number] => 12/518756 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6005 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291542.pdf [firstpage_image] =>[orig_patent_app_number] => 12518756 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/518756
RAPID IMMUNOCHROMATOGRAPHIC DETECTION BY AMPLIFICATION OF THE COLLOIDAL GOLD SIGNAL Dec 5, 2007 Abandoned
Array ( [id] => 12771 [patent_doc_number] => 07807173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Influenza vaccine formulation' [patent_app_type] => utility [patent_app_number] => 11/948505 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 22 [patent_no_of_words] => 7854 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807173.pdf [firstpage_image] =>[orig_patent_app_number] => 11948505 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/948505
Influenza vaccine formulation Nov 29, 2007 Issued
Array ( [id] => 6478576 [patent_doc_number] => 20100285106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'MULTICOMPONENT VACCINE' [patent_app_type] => utility [patent_app_number] => 12/312587 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11117 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285106.pdf [firstpage_image] =>[orig_patent_app_number] => 12312587 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/312587
MULTICOMPONENT VACCINE Nov 18, 2007 Abandoned
Array ( [id] => 5575001 [patent_doc_number] => 20090142362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)' [patent_app_type] => utility [patent_app_number] => 11/983039 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22955 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142362.pdf [firstpage_image] =>[orig_patent_app_number] => 11983039 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/983039
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP) Nov 5, 2007 Abandoned
Array ( [id] => 102659 [patent_doc_number] => 07728121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Hepatitis-C virus type 4, 5 and 6' [patent_app_type] => utility [patent_app_number] => 11/933672 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12096 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728121.pdf [firstpage_image] =>[orig_patent_app_number] => 11933672 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/933672
Hepatitis-C virus type 4, 5 and 6 Oct 31, 2007 Issued
Array ( [id] => 4715383 [patent_doc_number] => 20080237905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Preparation of polyphosphazene microspheres' [patent_app_type] => utility [patent_app_number] => 11/982028 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3245 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20080237905.pdf [firstpage_image] =>[orig_patent_app_number] => 11982028 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/982028
Preparation of polyphosphazene microspheres Oct 30, 2007 Abandoned
Array ( [id] => 5336737 [patent_doc_number] => 20090053201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'HEPATITIS B VIRAL VARIANTS WITH REDUCED SUSCEPTIBILITY TO NUCLEOSIDE ANALOGS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/932714 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 36115 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053201.pdf [firstpage_image] =>[orig_patent_app_number] => 11932714 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/932714
Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof Oct 30, 2007 Issued
Array ( [id] => 5436366 [patent_doc_number] => 20090170953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'INDENTIFICATION OF COMPOUNDS THAT INHIBIT REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS' [patent_app_type] => utility [patent_app_number] => 11/929695 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29185 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170953.pdf [firstpage_image] =>[orig_patent_app_number] => 11929695 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/929695
INDENTIFICATION OF COMPOUNDS THAT INHIBIT REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS Oct 29, 2007 Abandoned
Array ( [id] => 5490813 [patent_doc_number] => 20090291884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Proteins for use in diagnosing and treating infection and disease' [patent_app_type] => utility [patent_app_number] => 11/973920 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4933 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291884.pdf [firstpage_image] =>[orig_patent_app_number] => 11973920 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/973920
Proteins for use in diagnosing and treating infection and disease Oct 10, 2007 Abandoned
Array ( [id] => 4698226 [patent_doc_number] => 20080220410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'METHOD FOR REPLICATING THE HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 11/865954 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14097 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220410.pdf [firstpage_image] =>[orig_patent_app_number] => 11865954 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/865954
Nucleotide sequences coding for the non-structural proteins of the hepatitis C virus Oct 1, 2007 Issued
Array ( [id] => 4825743 [patent_doc_number] => 20080124763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Constructs and methods for expression of recombinant proteins in methylotrophic yeast cells' [patent_app_type] => utility [patent_app_number] => 11/902807 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 40067 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124763.pdf [firstpage_image] =>[orig_patent_app_number] => 11902807 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/902807
Constructs and methods for expression of recombinant proteins in methylotrophic yeast cells Sep 24, 2007 Abandoned
Array ( [id] => 81190 [patent_doc_number] => 07745130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/860727 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 33 [patent_no_of_words] => 36030 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745130.pdf [firstpage_image] =>[orig_patent_app_number] => 11860727 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/860727
Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof Sep 24, 2007 Issued
Array ( [id] => 159005 [patent_doc_number] => 07674578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy' [patent_app_type] => utility [patent_app_number] => 11/855238 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 4184 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674578.pdf [firstpage_image] =>[orig_patent_app_number] => 11855238 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/855238
Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy Sep 13, 2007 Issued
Array ( [id] => 4785465 [patent_doc_number] => 20080138794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Method for detecting or measuring HBV' [patent_app_type] => utility [patent_app_number] => 11/898419 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9699 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138794.pdf [firstpage_image] =>[orig_patent_app_number] => 11898419 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/898419
Method for detecting or measuring HBV Sep 11, 2007 Abandoned
Array ( [id] => 5416294 [patent_doc_number] => 20090042181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene' [patent_app_type] => utility [patent_app_number] => 11/898468 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9688 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042181.pdf [firstpage_image] =>[orig_patent_app_number] => 11898468 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/898468
Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene Sep 11, 2007 Issued
Array ( [id] => 5452598 [patent_doc_number] => 20090068635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 11/851050 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14245 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068635.pdf [firstpage_image] =>[orig_patent_app_number] => 11851050 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/851050
INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME Sep 5, 2007 Abandoned
Array ( [id] => 4676840 [patent_doc_number] => 20080214471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Method for inhibition of viral infection' [patent_app_type] => utility [patent_app_number] => 11/894365 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10700 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214471.pdf [firstpage_image] =>[orig_patent_app_number] => 11894365 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/894365
Method for inhibition of viral infection Aug 19, 2007 Abandoned
Array ( [id] => 4866323 [patent_doc_number] => 20080145382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/840708 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 46887 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145382.pdf [firstpage_image] =>[orig_patent_app_number] => 11840708 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/840708
RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF Aug 16, 2007 Abandoned
Menu